These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9892807)

  • 1. Targets for endothelin in the diseased kidney: clues for therapeutic intervention.
    Rohmeiss P; Birck R; Braun C; Kirchengast M; van der Woude FJ
    Exp Nephrol; 1999; 7(1):1-10. PubMed ID: 9892807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelin in renal function and dysfunction.
    Brooks DP
    Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):345-48. PubMed ID: 8717072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical role of endothelin antagonists.
    Gross P; Kirchengast M
    Nephrol Dial Transplant; 2001 Apr; 16(4):863-4. PubMed ID: 11274292
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelin receptors, renal effects and blood pressure.
    Boesen EI
    Curr Opin Pharmacol; 2015 Apr; 21():25-34. PubMed ID: 25544397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelin and kidney disease].
    Nakayama Y; Tomita K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():655-60. PubMed ID: 15506468
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelins: possibly a new pharmacological approach in cardiovascular diseases, kidney diseases and oncological disorders].
    Kroodsma JM; Rabelink AJ
    Ned Tijdschr Geneeskd; 1997 Sep; 141(38):1806-10. PubMed ID: 9545734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin, renal diseases, and hypertension.
    Dussaule JC; Boffa JJ; Tharaux PL; Fakhouri F; Ardaillou R; Chatziantoniou C
    Adv Nephrol Necker Hosp; 2000; 30():281-303. PubMed ID: 11068648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endothelin].
    Shirai K; Nakanishi T; Takamitsu Y
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():194-200. PubMed ID: 15250294
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelin-1-mediated inflammation in acute renal failure.
    Angerio AD
    Crit Care Nurs Q; 2006; 29(2):152-6. PubMed ID: 16641652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of endothelin receptor antagonism in kidney disease.
    Czopek A; Moorhouse R; Webb DJ; Dhaun N
    Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(5):R388-97. PubMed ID: 26702154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear neutrophils in acute renal failure: new insights.
    Caramelo C; Alvarez Arroyo MV
    Nephrol Dial Transplant; 1998 Sep; 13(9):2185-8. PubMed ID: 9761491
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelin B receptors preserve renal blood flow in a normotensive model of endotoxin-induced acute kidney dysfunction.
    Nitescu N; Grimberg E; Ricksten SE; Herlitz H; Guron G
    Shock; 2008 Mar; 29(3):402-9. PubMed ID: 17693943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking?
    Benigni A; Remuzzi G
    Nephrol Dial Transplant; 1998 Nov; 13(11):2734-8. PubMed ID: 9829469
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for eicosanoids in renal diseases.
    Câmara NO; Martins JO; Landgraf RG; Jancar S
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):21-7. PubMed ID: 19077685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies.
    Benigni A
    Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):349-53. PubMed ID: 7552102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
    Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.